Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics (NCT06401577)
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics (DREAM-ON) - An Observational Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)
🩺 Plain-English Summary (8th-Grade Level)
The DREAM-ON study will investigate whether continuous glucose monitoring (CGM) is useful to predict risk for developing diabetes mellitus (DM) and pre-diabetes mellitus (PDM), the need for insulin therapy among those who develop DM, and to determine whether CGM can provide insight into the pathophysiology and DM subtype among participants who have experienced an episode of acute pancreatitis (AP). Thus, the results of the DREAM-ON study could inform future clinical practice guidelines for the management AP as well as potentially extending the licensing authorization for CGM to include use in patients with pancreatogenic (Type 3c) DM.
Who can join: Review the eligibility criteria below.
Location: University of Southern California — Los Angeles, California
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (13 Sites)
- University of Southern California — Los Angeles, California
- Cedars-Sinai Medical Center — Los Angeles, California
- Stanford University — Stanford, California
- University of Florida — Gainesville, Florida
- AdventHealth — Orlando, Florida
- Northwestern University — Chicago, Illinois
- University of Illinois at Chicago — Chicago, Illinois
- Indiana University — Indianapolis, Indiana
- Johns Hopkins University — Baltimore, Maryland
- University of Minnesota — Minneapolis, Minnesota
- Ohio State University — Columbus, Ohio
- University of Pittsburgh — Pittsburgh, Pennsylvania
- Benaroya Research Institute — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (717) 531-3851
Email: rzimmerman1@pennstatehealth.psu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Acute Pancreatitis
- Diabetes RElated to Acute Pancreatitis and Its Mechanisms — Los Angeles, California
- Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase — Charlotte, North Carolina
- iMmune SignAtures and Clinical outComes in AP — Los Angeles, California
- DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis — Minneapolis, Minnesota
- A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis — Little Rock, Arkansas
Explore by condition: All Acute Pancreatitis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.